AAV9-mediated GAA gene therapy following enzyme replacement therapy discontinuation in children with infantile-onset Pompe disease

Xinting Liu, Yingying Mao, Linyan Hu, Wen He, Xiaodong Wang, Xueyuan Guo, Min Li, Yiru Wang, Yue Wang, Wenhao Ma, Yun Yuan, Zhaoxia Wang, Shuangqing Yu, Shu Zhang, Shiwen Wu, Xiaoyan Dong, Xiaobing Wu, Guang Yang · 2026

Read AAV9-mediated GAA gene therapy following enzyme replacement therapy discontinuation in children with infantile-onset Pompe disease by Xinting Liu, Yingying Mao, Linyan Hu, Wen He, Xiaodong Wang, Xueyuan Guo, Min Li, Yiru Wang, Yue Wang, Wenhao Ma, Yun Yuan, Zhaoxia Wang, Shuangqing Yu, Shu Zhang, Shiwen Wu, Xiaoyan Dong, Xiaobing Wu, Guang Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13427482.txt.

Description

Xinting Liu and coauthors report gene therapy after stopping enzyme treatment in children with infantile Pompe disease in a 2026 single-arm trial. Six children aged about 12 to 51 months got one intravenous infusion of AAV9 virus. The virus carried the GAA gene their bodies lack, and the children had previously received between 10 and 98 cycles of enzyme replacement therapy. Earlier work showed infants with minimal prior enzyme therapy stayed free of ventilators and enzyme infusions for at least a year after one dose.

Whether older children with long, high-dose enzyme exposure keep the same benefit after stopping treatment was unknown, so twelve months of follow-up tracked motor, breathing, and safety outcomes. Sustained benefit would reshape lifelong treatment for this muscle disease.

Catalog record

CREATORXinting Liu, Yingying Mao, Linyan Hu, Wen He, Xiaodong Wang, Xueyuan Guo, Min Li, Yiru Wang, Yue Wang, Wenhao Ma, Yun Yuan, Zhaoxia Wang, Shuangqing Yu, Shu Zhang, Shiwen Wu, Xiaoyan Dong, Xiaobing Wu, Guang Yang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE79436
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13427482

Browse the full library · About the Tower of Babel